This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: heart failure

Home- versus hospital-based exercise training in heart failure: an economic analysis

April 2014 Br J Cardiol 2014;21:76 doi:10.5837/bjc.2014.011 Online First

Home- versus hospital-based exercise training in heart failure: an economic analysis

Aynsley Cowie, Owen Moseley

Abstract

Introduction Heart failure (HF) costs the National Health Service (NHS) £625 million per year and accounts for 5% of all emergency medical hospital admissions in the UK.1,2 Interventions with the potential to reduce admissions and lessen this economic burden are always of clinical interest; however, any such potential for cost-avoidance must always be balanced against the financial cost of the intervention. While there is evidence to suggest that exercise training may reduce emergency admissions in HF,3,4 this research invariably focuses on training that includes a hospital-based component. Though exercising at home may offer a more practic

| Full text
High-sensitivity troponin T is detectable in most patients with clinically stable heart failure

March 2014 Br J Cardiol 2014;21:33–6 doi:10.5837/bjc.2014.005

High-sensitivity troponin T is detectable in most patients with clinically stable heart failure

Kristopher S Lyons, Gareth McKeeman, Gary E McVeigh, Mark T Harbinson

Abstract

(more…)

| Full text

December 2013 Br J Cardiol 2013;20:160

Correspondence: national survey of patients with AF in the acute medical unit: a day in the life survey

Dr John Havard; Dr John Soong

Abstract

National survey of patients with AF in the acute medical unit: a day in the life survey Dear Sirs, The first national survey examining the management of atrial fibrillation (AF) within acute medical units up and down the country has just been published in the British Journal of Cardiology.1 Essentially it seems to show that secondary care is just as bad as primary care in initiating warfarin for AF patients. This group of patients is five times more likely to have a thromboembolic cerebrovascular accident than matched populations in sinus rhythm and yet doctors are ineffective at influencing change. This study took place over a 24-hour period

| Full text
Echocardiography is not indicated for an enlarged cardiothoracic ratio

November 2013 Br J Cardiol 2013;20:149–150 doi:10.5837/bjc.2013.30

Echocardiography is not indicated for an enlarged cardiothoracic ratio

Lucinda Wingate-Saul, Yassir Javaid, John Chambers

Abstract

(more…)

| Full text
Assessing the health-related quality of life in patients hospitalised for acute heart failure

April 2013 Br J Cardiol 2013;20:72–6 doi:10.5837/bjc.2013.013 Online First

Assessing the health-related quality of life in patients hospitalised for acute heart failure

Paul Swinburn, Sarah Shingler, Siew Hwa Ong, Pascal Lecomte, Andrew Lloyd

Abstract

Introduction Acute heart failure (AHF) has been defined by the European Society of Cardiology (ESC) as the rapid onset of, or change in, symptoms and signs of heart failure, and is a life-threatening condition that requires immediate medical attention.1 These symptoms and signs include shortness of breath at rest or during exertion, fatigue, pulmonary or peripheral fluid retention, a cough, and evidence of an abnormality of the structure or function of the heart at rest.2-4 This change in cardiac function results in an urgent need for therapy, and AHF is among the most common causes of hospitalisation.5 AHF can, therefore, be seen to represen

| Full text
The SERVE-HF study: investigating the impact of central sleep apnoea on heart failure

April 2013 Br J Cardiol 2013;20:50–1 doi:10.5837/bjc.2013.011 Online First

The SERVE-HF study: investigating the impact of central sleep apnoea on heart failure

Martin Cowie

Abstract

An overlooked form of SDB Professor Martin Cowie Another form of sleep apnoea – central sleep apnoea with Cheyne Stokes respiration (CSA-CSR) – has received less in-depth investigation than OSA. Nonetheless, it carries significant importance, particularly in heart failure patients. Moderate-to-severe forms have been reported to occur in up to 50% of chronic heart failure patients.4-7 Unlike OSA patients, whose loud night-time snores are punctuated with dramatic apnoeic episodes, CSA-CSR patients exhibit a different style of breathing. In this patient group, night-time breathing follows a waxing and waning pattern in which successive breat

| Full text
Underuse of beta blockers in patients with heart failure

March 2013 Br J Cardiol 2013;20:11–13 doi:10.5837/bjc.2013.005

Underuse of beta blockers in patients with heart failure

Laxman Dubey, Paul Kalra, Henry Purcell

Abstract

Our letter from Nepal below shows underuse of beta blockers is a widespread problem As outlined in the recent European Society of Cardiology (ESC) guidelines for the treatment of heart failure,1 the pivotal trials with beta blockers were conducted in patients with continuing symptoms and a persistently low ejection fraction (EF), despite treatment with an ACE inhibitor and, in most cases, a diuretic. Despite this, “there is consensus that these treatments are complementary and that a beta blocker and an ACE inhibitor should both be started as soon as possible after diagnosis of heart failure with reduced ejection fraction (HF-REF)”.1

| Full text
Acute heart failure – a call to action

March 2013 Br J Cardiol 2013;20(suppl 2):S1–S11 doi:10.5837/bjc.2013.s02

Acute heart failure – a call to action

Professor Martin Cowie, Professor Derek Bell, Mrs Jane Butler, Professor Henry Dargie, Professor Alasdair Gray, Professor Theresa McDonagh, Dr Hugh McIntyre, Professor Iain Squire, Dr Jacqueline Taylor, Ms Helen Williams

Abstract

(more…)

| Full text
News from the BSH 15th Annual Autumn Meeting

February 2013 Br J Cardiol 2013;20:18-9

News from the BSH 15th Annual Autumn Meeting

Abstract

Mineralocorticoid receptor antagonists Professor Faiez Zannad (Université de Lorraine, Nancy, France), the first of two guest lecturers, who has been an investigator in three major randomised controlled trials (RCT) of mineralocorticoid receptor antagonists (MRA) in heart failure,1-3 opened the first session. There was a particular focus on the recent EMPHASIS-HF trial,3 which recruited heart failure (HF) patients with left ventricular systolic dysfunction (ejection fraction [EF] ≤30%, or EF 30-35% with QRS duration >130 ms) and mild symptoms (New York Heart Association [NYHA] class II). Eplerenone treatment resulted in a 37% relative

| Full text

February 2013 Online First

British Society of Heart Failure Young Investigators’ Award

Abstract

Multipolar left ventricular pacing to optimise acute haemodynamic response to cardiac resynchronisation therapy SY Ahsan (presenting author), B Sabberwal, C Hayward, P Lambiase, M Thomas, GG Babu, S Aggarwal, MD Lowe, AWC Chow The Heart Hospital, Institute of Cardiovascular Science, University College Hospitals NHS Foundation Trust, London Purpose: Cardiac resynchronisation therapy (CRT) reduces morbidity and mortality in a sub-group of patients with heart failure, though up to 30% of patients have no benefit. CRT patients are heterogeneous and an individualised approach to CRT may be needed to increase response rate. We evaluated the impact

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now